戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 he DSEC (containing 19 ingredients including ephedra [12 mg] and caffeine [40 mg]) or matching placeb
2                          Products containing ephedra accounted for 64% of all adverse reactions to he
3             Dietary supplements that contain ephedra alkaloids (sometimes called ma huang) are widely
4                     Concomitant ingestion of ephedra alkaloids and water produced a greater increase
5                                   The use of ephedra alkaloids in over-the-counter preparations has b
6     We therefore investigated the effects of ephedra alkaloids in patients with autonomic impairment
7                                              Ephedra alkaloids increase blood pressure significantly
8  The use of dietary supplements that contain ephedra alkaloids may pose a health risk to some persons
9 to the use of dietary supplements containing ephedra alkaloids that were submitted to the FDA between
10 ted to the use of supplements that contained ephedra alkaloids to assess causation and to estimate th
11 related to the use of supplements containing ephedra alkaloids, 47 percent involved cardiovascular sy
12 related to the use of supplements containing ephedra alkaloids, and 31 percent were deemed to be poss
13  to understand the cardiovascular effects of ephedra alkaloids, but these are normally masked by baro
14 lar complications associated with the use of ephedra alkaloids, given that baroreflex function varies
15                                 No trials of ephedra and athletic performance were found; 7 trials of
16 multicomponent dietary supplement containing ephedra and caffeine (DSEC) in addition to several other
17  identified trials of efficacy and safety of ephedra and ephedrine on weight loss or athletic perform
18                                              Ephedra and ephedrine sometimes are used for weight loss
19  and caffeine (n = 12), ephedra (n = 1), and ephedra and herbs containing caffeine (n = 4) yielded es
20 known athletes have highlighted the risks of ephedra, and some research suggests that complementary a
21                                          The ephedra- and caffeine-containing dietary supplement Meta
22 and ginseng; cardiovascular instability from ephedra; and hypoglycemia from ginseng.
23 ption products phenylpropanolamine (PPA) and ephedra are of particular interest because of recent saf
24 nsengs; Siberian ginseng, mahuang or Chinese ephedra; ashwagandha; rhodiola; yohimbe; CORDYCEPS: fung
25 e mature pollen from diverse angiosperms and Ephedra but not from lower gymnosperms, suggesting that
26 sks for an adverse reaction in persons using ephedra compared with other herbs were extremely high, r
27                              A suite of five ephedra-containing dietary supplement Standard Reference
28 ssor Association laboratories for one of the ephedra-containing SRMs.
29  weight loss, and evidence to support use of ephedra for athletic performance is insufficient.
30 ted to dietary supplements containing herbal ephedra from FDA MedWatch files as of Sept. 30, 2001.
31                                   Echinacea, ephedra, garlic, ginkgo, ginseng, kava, St John's wort,
32                                              Ephedra is widely used in dietary supplements that are m
33 ne (n = 5), ephedrine and caffeine (n = 12), ephedra (n = 1), and ephedra and herbs containing caffei
34                                       Use of ephedra or ephedrine and caffeine is associated with inc
35   Eligible studies were controlled trials of ephedra or ephedrine used for weight loss or athletic pe
36        Eligible case reports documented that ephedra or ephedrine was consumed within 24 hours prior
37 ined by three processes: extraction from the Ephedra plant ("natural"), via fermentation of sugars ("
38 ct use, 2% reported PPA use, and 1% reported ephedra product use.
39                                Ephedrine and ephedra promote modest short-term weight loss (approxima
40 e identified: chitosan, chromium picolinate, Ephedra sinica, Garcinia cambogia, glucomannan, guar gum
41 vidence regarding the efficacy and safety of ephedra, the authors describe data on psychiatric advers
42 l for experiencing an adverse reaction after ephedra use compared with other herbs.
43                                              Ephedra use is associated with a greatly increased risk
44 sychiatric symptoms could be associated with ephedra use.
45 defined as the ratio of adverse reactions to ephedra versus other products, divided by the ratio of t
46 m lineage Gnetales (Gnetum, Welwitschia, and Ephedra), with especially dense sampling in Gnetum for w

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。